Edgewise Therapeutics, Inc. Quarterly Operating Lease, Right-of-Use Asset in USD from Q1 2022 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Edgewise Therapeutics, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q1 2022 to Q2 2024.
  • Edgewise Therapeutics, Inc. Operating Lease, Right-of-Use Asset for the quarter ending June 30, 2024 was $2.05M, a 13% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $2.05M -$306K -13% Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $2.2M -$195K -8.16% Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $2.25M +$929K +70.5% Dec 31, 2023 10-Q 2024-08-08
Q3 2023 $2.3M +$975K +73.8% Sep 30, 2023 10-Q 2023-11-09
Q2 2023 $2.35M +$782K +49.8% Jun 30, 2023 10-Q 2023-08-10
Q1 2023 $2.39M +$260K +12.2% Mar 31, 2023 10-Q 2023-05-11
Q4 2022 $1.32M Dec 31, 2022 10-K 2024-02-22
Q3 2022 $1.32M Sep 30, 2022 10-Q 2022-11-03
Q2 2022 $1.57M Jun 30, 2022 10-Q 2022-08-04
Q1 2022 $2.13M Mar 31, 2022 10-Q 2022-05-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.